The store will not work correctly when cookies are disabled.
2-(4-(4-Chlorophenyl)piperazin-1-yl)-3-hydroxynaphthalene-1,4-dione
ID: ALA4474026
PubChem CID: 155536717
Max Phase: Preclinical
Molecular Formula: C20H17ClN2O3
Molecular Weight: 368.82
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(O)=C(N2CCN(c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21
Standard InChI: InChI=1S/C20H17ClN2O3/c21-13-5-7-14(8-6-13)22-9-11-23(12-10-22)17-18(24)15-3-1-2-4-16(15)19(25)20(17)26/h1-8,26H,9-12H2
Standard InChI Key: YVSSKYRZGDZBSW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
8.9123 -26.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6227 -26.7095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3376 -26.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3403 -25.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6222 -25.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9101 -25.4720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2061 -22.9864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2050 -23.8135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9196 -24.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9179 -22.5736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6331 -22.9827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6319 -23.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3447 -24.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0632 -23.8131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0644 -22.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3470 -22.5673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3471 -21.7425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3424 -25.0487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7797 -22.5740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7764 -24.2274 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7689 -25.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4780 -25.4633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1958 -25.0564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2002 -24.2306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4866 -23.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0506 -26.7146 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
13 18 2 0
15 19 1 0
14 20 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
23 6 1 0
3 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.82 | Molecular Weight (Monoisotopic): 368.0928 | AlogP: 3.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 60.85 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.03 | CX Basic pKa: 2.71 | CX LogP: 2.98 | CX LogD: 2.46 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.88 | Np Likeness Score: -0.60 |
References
1. Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695] [10.1016/j.ejmech.2019.02.018] |